What is the most appropriate regimen for untreated Waldenstr öm macroglobulinemia? - An updated analysis of rituximab and half-dose CHOP therapy and cost effectiveness.
What is the most appropriate regimen for untreated Waldenström macroglobulinemia? - An updated analysis of rituximab and half-dose CHOP therapy and cost effectiveness.
Blood Res. 2019 Jun;54(2):153-156
Authors: Sekiguchi N, Hamano A, Kitagawa T, Ito K, Hirano K, Yamada K
PMID: 31309097 [PubMed]
Source: Blood Research - Category: Hematology Tags: Blood Res Source Type: research